Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy (NCT05198245)

🧪 Interventions in This Study

• Rimegepant (DRUG)
• Various (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Pfizer — New York, New York

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Migraine

• A Study of Wearable Devices to Predict Migraines — Rochester, Minnesota
• Treatment for Migraine and Mood — The Bronx, New York
• Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine — Birmingham, Alabama
• A Study to Evaluate White Matter Hyperintensities in Migraine — Phoenix, Arizona
• Migraine Manager (R01) — Cincinnati, Ohio
• Nerivio Efficacy Under High-Frequency Use — Bridgewater, New Jersey

Explore by condition: All Migraine clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.